Hepatitis Vaccines: Recommended For Children, Patients Suffering From Chronic Liver Diseases
Hepatitis vaccine |
Hepatitis
vaccine is one of the most critical vaccines recommended for the prevention of
hepatitis A and hepatitis B. Since its introduction, hepatitis vaccination
rates have been increasing steadily in countries like the U. S. In May 2019,
according to the study, ‘Prevalence of hepatitis B surface antigen (HBsAg)
positivity and its associated factors in Rwanda’, published in May 2019, in BMC
Infectious Diseases, the prevalence of hepatitis B surface antigen was 3.9% in
the study population.
Acute viral
hepatitis is inflammation of the liver caused by infection with one of the five
hepatitis viruses. In the U.S., rates of new Hepatitis B infections are highest
among adults aged 40-49 years, reflecting low hepatitis B vaccination coverage
among adults at risk. Persons with chronic conditions like diabetes and
HIV/AIDS are also at increased risk of contracting hepatitis B.
Since the hepatitis
vaccine was introduced, worldwide, 500 million people are estimated to
be infected with hepatitis B or C. These viruses kill 1.5 million people a
year; The U.S recorded 12,474 new cases of hepatitis A in 2018, 3,322 of new
hepatitis B cases, and 4,768 of
hepatitis C cases in 2018. Unprotected sex can result in contagious hepatitis
B, which can be easily transmitted to other people. People who have unprotected
sexual intercourse with a person infected with hepatitis B virus can develop
chronic hepatitis, a serious complication of hepatitis B infection.
Hepatitis
vaccine for type B is made from parts of the hepatitis B virus. The vaccine is
usually given as 2, 3, or 4 shots over 1 to 6 months. Hepatitis A vaccine is
administered by injection into the muscle of the upper arm. Unvaccinated people
traveling to countries where hepatitis A is common are recommended to get
vaccinated against hepatitis A.
Comments
Post a Comment